Lusky M[au] - Search Results

Year	Number of Results
1979	3
1981	2
1982	1
1983	1
1984	1
1985	2
1986	5
1987	3
1988	3
1989	3
1990	1
1991	2
1992	4
1993	6
1994	4
1995	2
1996	1
1997	3
1998	2
1999	3
2000	3
2001	2
2002	2
2003	2
2004	1
2005	6
2006	3
2007	2
2008	1
2009	1
2010	4
2013	2
2014	1
2017	1
2018	2
2019	2
2020	1
2022	2

1

The bovine papillomavirus replicon.

Botchan M, Berg L, Reynolds J, Lusky M. Botchan M, et al. Among authors: lusky m. Ciba Found Symp. 1986;120:53-67. doi: 10.1002/9780470513309.ch5. Ciba Found Symp. 1986. PMID: 3013526 Review.

2

Early isolated optic neuropathy caused by cyclosporine.

Mimouni K, Lusky M, Kramer M, Gdalevich M, Weinberger D, Mimouni M. Mimouni K, et al. Among authors: lusky m. Int Ophthalmol. 2019 Apr;39(4):853-860. doi: 10.1007/s10792-018-0886-2. Epub 2018 Mar 12. Int Ophthalmol. 2019. PMID: 29532216

3

Transductional targeting with recombinant adenovirus vectors.

Legrand V, Leissner P, Winter A, Mehtali M, Lusky M. Legrand V, et al. Among authors: lusky m. Curr Gene Ther. 2002 Sep;2(3):323-39. doi: 10.2174/1566523023347823. Curr Gene Ther. 2002. PMID: 12189719 Review.

4

Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site.

Lusky M, Hurwitz J, Seo YS. Lusky M, et al. J Biol Chem. 1993 Jul 25;268(21):15795-803. J Biol Chem. 1993. PMID: 8393453 Free article.

5

Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.

Lusky M, Grave L, Dieterlé A, Dreyer D, Christ M, Ziller C, Furstenberger P, Kintz J, Hadji DA, Pavirani A, Mehtali M. Lusky M, et al. J Virol. 1999 Oct;73(10):8308-19. doi: 10.1128/JVI.73.10.8308-8319.1999. J Virol. 1999. PMID: 10482581 Free PMC article.

6

Good manufacturing practice production of adenoviral vectors for clinical trials.

Lusky M. Lusky M. Hum Gene Ther. 2005 Mar;16(3):281-91. doi: 10.1089/hum.2005.16.281. Hum Gene Ther. 2005. PMID: 15812223 Review.

7

Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors.

Lusky M, Botchan MR. Lusky M, et al. J Virol. 1985 Mar;53(3):955-65. doi: 10.1128/JVI.53.3.955-965.1985. J Virol. 1985. PMID: 2983102 Free PMC article.

8

Changes in anterior segment parameters following insertion of ExPRESS mini glaucoma implant vs. trabeculectomy.

Livny E, Hammel N, Mimouni M, Lusky M, Kaiserman I, Bahar I. Livny E, et al. Among authors: lusky m. Arq Bras Oftalmol. 2020 Aug;83(4):283-288. doi: 10.5935/0004-2749.20200040. Epub 2020 Jul 29. Arq Bras Oftalmol. 2020. PMID: 32756788 Free article.

9

Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.

Diestelhorst M, Krieglstein GK, Lusky M, Nagasubramanian S. Diestelhorst M, et al. Among authors: lusky m. Surv Ophthalmol. 1997 Feb;41 Suppl 2:S77-81. doi: 10.1016/s0039-6257(97)80011-2. Surv Ophthalmol. 1997. PMID: 9154280 Review.

10

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.

Ricordel M, Foloppe J, Antoine D, Findeli A, Kempf J, Cordier P, Gerbaud A, Grellier B, Lusky M, Quemeneur E, Erbs P. Ricordel M, et al. Among authors: lusky m. Cancers (Basel). 2018 Jul 10;10(7):231. doi: 10.3390/cancers10070231. Cancers (Basel). 2018. PMID: 29996551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results